Placebo Effects in Neurologic Disease

Natalie Witek is at Rush Parkinson’s Disease and Movement Disorders Program, USA Professor and Associate Chairman, Department of Neurological Sciences, Rush University, Rush-Presbyterian-St. Luke's Medical Center, Chicago, ILProfessor of Neurological Science Glenn Stebbins is at Rush Parkinson’s Disease and Movement Disorders Program, USA

• Part 1: Background and methods in placebo Better than nothing: A historical account of placebos and placebo effects from modern to contemporary medicineMarco AnnoniDeterminants of placebo effectsSharlet Anderson and Glenn T. StebbinsStrategies to minimize placebo effects in research investigationsFilipe B Rodrigues and Joaquim J FerreiraMaximizing placebo response in neurological clinical practiceLouise-Laure Mariani and Jean-Christophe CorvolStatistical methods in handling placebo effectRema RamanNocebo and lessebo effects Tiago A. MestreDeception and the ethics of placeboA. Jon StoesslPart 2: Placebo response in specific disease populationsPlacebo effects in painLuana CollocaPlacebo responses in Parkinson's diseaseJau-Shin LouPlacebo effect in subjects with cognitive impairmentKaori Ito and Klaus RomeroPlacebo in epilepsy Daniel M. Goldenholz and Shira R. Goldenholz